EFFECT OF WAY-100135 ON THE HIPPOCAMPAL ACETYLCHOLINE-RELEASE POTENTIATED BY 8-OH-DPAT, A SEROTONIN(1A) RECEPTOR AGONIST, IN NORMAL AND P-CHLOROPHENYLALANINE-TREATED RATS AS MEASURED BY IN-VIVO MICRODIALYSIS
K. Nakai et al., EFFECT OF WAY-100135 ON THE HIPPOCAMPAL ACETYLCHOLINE-RELEASE POTENTIATED BY 8-OH-DPAT, A SEROTONIN(1A) RECEPTOR AGONIST, IN NORMAL AND P-CHLOROPHENYLALANINE-TREATED RATS AS MEASURED BY IN-VIVO MICRODIALYSIS, Neuroscience research, 31(1), 1998, pp. 23-29
The mechanisms involved in the enhancement of acetylcholine (ACh) rele
ase in the rat hippocampus by 8-hydroxy-2-(di-n-propylamino)tetralin (
8-OH-DPAT), a serotonin (5-HT)(1A) receptor agonist, were investigated
using in vivo microdialysis. Administration of p-chlorophenylalanine
(PCPA, 300 mg/kg, i.p.), a tryptophan hydroxylase inhibitor, 3 days be
fore the dialysis experiments reduced the hippocampal 5-HT content to
30% of that in saline-treated rats, but did not affect basal ACh relea
se in the hippocampus. 8-OH-DPAT administered systemically (0.5 mg/kg,
s.c.) or applied locally (30 mu M) into the hippocampus through the d
ialysis probe significantly enhanced the release of ACh in the hippoca
mpus of PCPA-treated rats to the same degree as that in saline-treated
rats. Pretreatment with (+)WAY-100135 (5 mg/kg, i.p.), a selective 5-
HT1A receptor antagonist, completely eliminated the enhancement of ACh
release induced by locally applied 8-OH-DPAT, but only partially redu
ced the effects induced by systemically administered 8-OH-DPAT, in bot
h groups of rats. Systemically administered 8-OH-DPAT induced hyperloc
omotion in the both saline- and PCPA-treated rats, but this was not el
iminated by(+)WAY-100135. 8-OH-DPAT applied locally into the hippocamp
us did not elicit hyperlocomotion in either group of rats. These resul
ts suggest that the modification of endogenous 5-HT release via the 5-
HT1A autoreceptor is not involved in the 8-OH-DPAT-induced increase of
hippocampal ACh release, and that the increase of ACh release induced
by locally applied 8-OH-DPAT involves mainly hippocampal postsynaptic
5-HT1A receptor stimulation. In addition, a possibility that subtypes
of 5-HT receptors other than the 5-HT1A receptor, probably 5-HT7 rece
ptor in the septum as well as postsynaptic 5-HT1A receptor in the hipp
ocampus, are involved in the increased hippocampal ACh release induced
by systemically administered 8-OH-DPAT is discussed. (C) 1998 Elsevie
r Science Ireland Ltd. All rights reserved.